Radiogenomics study for glioma treatment sensitivity
Part of Cancer clinical trials.
This study looks at MRI scans and genetic information to understand which gliomas respond best to radiation and chemotherapy. It may help doctors predict treatment success based on your scans.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- You have been diagnosed with a glioma (a type of brain tumor).
- You have not had any other brain tumors or brain surgery before.
- You have not had radiation therapy or chemotherapy before starting this study.
- You have MRI scans available from before your surgery, after surgery (before radiation), and after radiation therapy.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial uses a special MRI scan to study the genetics of gliomas (a type of brain tumor). It may help doctors better understand your tumor and choose the right treatment. You can join if you have a suspected or confirmed low- or high-grade glioma that still has a measurable tumor after surgery.
This study uses MRI scans to find higher-risk areas in certain brain and other solid tumors and help plan radiation treatment. It also looks for changes in tumor “metabolites” (chemicals in the tumor) that may relate to how the tumor behaves.
This trial uses artificial intelligence to analyze MRI scans from people diagnosed with a type of brain tumor called glioma. It aims to better understand the cancer from diagnosis through treatment, which could help guide future care.
This trial is for people with glioma who have tumor tissue or blood samples stored. It uses artificial intelligence to analyze these samples and find the best treatment. You might be eligible if you are at least 18 years old and have had a glioma diagnosis with tissue available for study.
This study uses brain MRI images and tumor tissue to predict the tumor’s molecular (cell-level) features in people with glioma. It may help doctors better understand glioma biology and plan care based on noninvasive imaging plus lab testing.
This study looks at MRI scans to find “molecular markers” that may reflect how active a brain tumor is. If you’re having surgery for a primary brain tumor, these scan results may help researchers better understand tumor behavior.
Hear when a new Glioma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.